MDPH Prostate Cancer PSA « CBS Boston

Support MPCC


1 out of 36 men will die of prostate cancer. Get involved.

Our Focus

Our Focus

The Massachusetts Prostate Cancer Coalition (MPCC) educates, connects, and supports men-at-risk, newly diagnosed individuals, survivors, and their families. It also connects organizations and professionals in Massachusetts that seek to conquer and cure prostate cancer.

Support MPCC by becoming a member, making a donation or attending an event. More information can be found here.


Five Facts about Prostate Cancer

Five Facts about Prostate Cancer
  1. 1
    Prostate cancer is the most common (non-skin) cancer in American men.
  2. 2
    Prostate cancer effects 1 in 7 men.
    1 in 7 men will be diagnosed with prostate cancer during their lifetime. This year in Massachusetts another 4,762 new cases will be diagnosed.
  3. 3
    Second leading cause of cancer death in men.
    Prostate cancer is the second leading cause of cancer death in American men, behind only lung cancer. In Massachusetts, 614 men will die from prostate cancer this year.

  4. 4
    Prostate cancer top risk factors.


    African-American men are twice as likely to die of prostate cancer as white men. Asian-Americans and Hispanic/Latinos have lower rates of prostate cancer than non-Hispanic white men.


    Prostate cancer occurs mainly in older men. About 6 cases in 10 are diagnosed in men aged 65 or older, and it is rare before age 40. The average age at the time of diagnosis is about 66.

  5. 5
    This year 27,540 men will die of prostate cancer.

    Yet, most men diagnosed with prostate cancer will not die from it. In fact, more than 2.9 million men in the United States who have been diagnosed with prostate cancer at some point are still alive today.

Statistics from The American Cancer Society 2013

We need your support! Become a Member or Donate to MPCC today.

Exercise has the highest potential preventative impact when it comes to developing lethal prostate cancer. (Stocksy) Read more read more →

(HealthDay News) — Magnetic resonance imaging-ultrasound fusion targeted prostate biopsy (MRF-TB) improves detection and risk stratification of high-grade disease and limits detection of clinically insignificant prostate cancer, according to a study published in The Journal of Urology Read more read more →